ARE-Nrf2 Luciferase Test Method (OECD TG 442D)

With the development of reliable in chemico/in vitro assays, manufacturers and formulators are now able to determine whether or not a substance is a skin sensitizing agent without the need for animal testing. Each of the available assays recapitulates some element of the adverse outcome pathway (AOP) associated with a skin sensitization response in humans. Using an integrated testing strategy that incorporates these approaches for identifying skin sensitization hazard risk (as outlined by the Globally Harmonized System of Classification and Labelling of Chemicals) ensures regulatory compliance as well as consumer safety and satisfaction.

Overview of ARE-Nrf2 Luciferase Test Method

The ARE-Nrf2 Luciferase Test is an in vitro test method that models the second key event in the skin sensitization adverse outcome pathway. When the skin is repeatedly exposed to a skin sensitizer, a sensitizing substance may cause skin cells (i.e., keratinocytes) to activate a protective gene pathway linked to skin sensitization. The more robust the keratinocyte response, the greater the sensitization potential of the substance.

The ARE-Nrf2 Luciferase Test measures the activation of this protective gene pathway—the antioxidant/electrophile response element (ARE) pathway—using luminescence-based detection. This assay uses a modified keratinocyte line that contains a luciferase gene under the transcriptional control of a constitutive promoter fused with the ARE element. When exposed to a sensitizer, endogenous Nrf2-dependent genes are activated. Luciferase-driven luminescence is well-documented to be dependent on Nrf2 expression. A Luminometer is used to quantify luciferase output in response to test materials. The ARE-Nrf2 Test classifies materials as positive for skin sensitization capacity if they induce a statistically significant luminescent signal that exceeds a defined threshold.

The ARE-Nrf2 Luciferase Test is suitable for testing multi-constituent substances and mixtures and is more likely to predict low to moderate skin sensitization potential as opposed to high skin sensitization potential. This assay also should be used in conjunction with additional assays to confidently determine a substance’s safety and skin sensitization potential.

Our Capabilities

CPTSM is a state-of-the-art testing facility, including laboratories that specialize in Analytical, Clinical, and In-Vitro Toxicology testing. Our entire testing facility is at your disposal for evaluating skin sensitization potential.

In our highly experienced and specialized departments, we test a wide range of articles including pharmaceuticals, raw materials, cosmetic and personal care products. Our experts offer our clients guidance on the best testing strategies to ensure consumer safety and satisfaction as well as regulatory compliance.

Our Departments

Based on the individual needs of our clients, we offer a wide range of support across various departments. Since initial product testing can be fairly complex in terms of a high-quality, safe and trusted product, our clients typically explore the benefits of numerous departments and areas of expertise, including:

  • Clinical — Efficacy trials can be performed for safety, consumer in-use, and to support claims such as ‘dermatologist-tested’ and ‘ophthalmologist-tested.’
  • In-Vitro Toxicology — Our In-Vitro Toxicology department assists clients when they are looking to perform non-animal (animal-free) toxicology testing.
  • Microbiology — Microbial contamination and preservative efficacy testing are key to cosmetic and OTC drug products.
  • Photobiology — From SPF and Water-Resistant claims to Photoallergy and Phototoxicity studies, CPT℠ is the world leader in sunscreen testing.
  • Analytical — From raw materials, product batch release, and stability shelf-life testing to “free-of” and low-level detection claims, our analytical department ensures that all requirements are met based on industry standards.
  • Consulting – Our consulting staff can perform GMP and GLP audits of your facilities or vendors, help create SOPs, develop testing programs, etc.

Get In Touch

Please Note: CPT℠ only performs testing for companies. We do not perform product testing for the general public.

CPT℠ is closed January 16, 2023 in observance of Martin Luther King, Jr. Day.
Normal business hours will resume on Tuesday, January 17th.